Table 2.
The associations of dietary fiber consumption with NAFLD and CSF.
| Liver diseases | Dietary fiber consumption | Per 1-SD | Ptrendc | ||
|---|---|---|---|---|---|
| Tertile 1 | Tertile 2 | Tertile 3 | |||
| NAFLD (ORs and 95% CIs) | |||||
| Model 1a | 1 | 1.07 (0.91–1.25) | 1.01 (0.86–1.19) | 0.98 (0.92–1.04) | 0.458 |
| Model 2b | 1 | 0.95 (0.79–1.14) | 0.81 (0.66–0.98) | 0.89 (0.82–0.97) | 0.008 |
| CSF (ORs and 95% CIs) | |||||
| Model 1a | 1 | 1.09 (0.82–1.44) | 0.95 (0.71–1.26) | 0.91 (0.80–1.03) | 0.131 |
| Model 2b | 1 | 0.91 (0.67–1.25) | 0.81 (0.58–1.14) | 0.87 (0.75–1.01) | 0.068 |
CIs, confidence intervals; CSF, clinically significant fibrosis; ORs, odds ratios.
a
Model 1 did not adjust for the covariates.
b
Model 2 was adjusted for age, sex, smoking, race/ethnicity, education, ratio of family income to poverty, physical activity, total energy, hypertension, and diabetes.
c
The trend test was performed by using z-score in the models.